UK Statutory Instrument
2024
United Kingdom
The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024
At a glance
What this Act requires
Sections that create concrete duties on businesses or carry penalties. Procedural and definitional sections are folded into the “Browse other sections” expander at the bottom of each group. Click any section title to read the source text on legislation.gov.uk.
Browse 9 other sections — procedural / definitional / commencement
Interpretation
Definition of “supply”, which includes an exclusion from the scope of this Order of supplies for the purposes of an authorised clinical trial
Prohibition on the sale or supply of medicinal products consisting of or containing gonadotrophin-releasing hormone analogues
Exception for all NHS prescriptions
Exception for private prescriptions: patients aged 18 or over
Exception for private prescriptions: patients aged under 18 – treatment for a purpose other than puberty suppression in respect of gender dysphoria etc.
Exception for private prescriptions: patients aged under 18 – treatment for the purposes of puberty suppression in respect of gender dysphoria etc.
Reviews
Explore more
Browse legislation
Find other UK business legislation with related guidance.